Related Experiment Videos
Colchicine-induced myopathy and neuropathy
1Department of Geriatrics, Caritas Medical Centre, 111 Wing Hong Street, Shamshuipo, Hong Kong.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|February 1, 2002
Summary
Colchicine can cause myopathy and neuropathy, particularly in patients with kidney issues. Stopping the drug led to significant recovery from the muscle condition.
Area of Science:
- Neurology
- Toxicology
- Pathology
Background:
- Colchicine is a commonly prescribed medication.
- Colchicine-induced myopathy and neuropathy are rare but serious adverse effects.
- Renal impairment may increase the risk of colchicine toxicity.
Purpose of the Study:
- To report a case of colchicine-induced myopathy and neuropathy in an elderly patient with renal impairment.
- To highlight the diagnostic features of colchicine-induced myopathy.
- To emphasize the importance of early diagnosis and drug cessation for patient recovery.
Main Methods:
- A case study of an 84-year-old woman with colchicine-induced myopathy and neuropathy.
- Review of clinical presentation, laboratory findings, and muscle biopsy results.
- Assessment of treatment response after colchicine withdrawal.
Main Results:
- The patient presented with symptoms of myopathy and neuropathy.
- Muscle biopsy revealed characteristic vacuolar myopathy with autophagic vacuoles.
- Discontinuation of colchicine resulted in substantial improvement of myopathy symptoms.
Conclusions:
- Colchicine toxicity can manifest as myopathy and neuropathy, especially in patients with compromised renal function.
- Muscle biopsy is crucial for diagnosing colchicine-induced myopathy.
- Prompt cessation of colchicine can lead to significant clinical improvement.